TAS1R1 and lung adenocarcinoma: Kaplan–Meier survival analyses for high- and low-expression groups of TAS1R1 was statistically significant for lung adenocarcinoma (p = 0.0069) but not for kidney papillary cell carcinoma (p = 0.051) or cervical esophageal squamous cell carcinoma (p = 0.056, Fig. 6F–H).